These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 644593)

  • 1. The effect of oral chenodeoxycholic acid on cholesterol solubility in hepatic bile.
    Matsushiro T; Kobayashi N; Suzuki N; Yamauchi H; Sato T
    Tohoku J Exp Med; 1978 Feb; 124(2):187-96. PubMed ID: 644593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of choledocholithiasis with oral chenodeoxycholic acid.
    Sue SO; Taub M; Pearlman BJ; Marks JW; Bonorris GG; Schoenfield LJ
    Surgery; 1981 Jul; 90(1):32-4. PubMed ID: 7017991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The goose that laid the golden bile: gallstone dissolution in man with chenodeoxycholic acid.
    Dowling RH
    Ir J Med Sci; 1974 Jul; 0(0):suppl:115-27. PubMed ID: 4212419
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1979 Aug; 77(2):223-30. PubMed ID: 447035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
    Iser JH; Maton PN; Murphy GM; Dowling RH
    Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in serum total cholesterol and low-density lipoprotein cholesterol by high-dose chenodeoxycholic acid in patients with radiolucent gallstones significantly reversed during preventive low dose after gallstone dissolution.
    Pérez-Aguilar F; Bretó M; Alegre B; Berenguer J
    Digestion; 1985; 31(4):225-33. PubMed ID: 4007294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Per oral gallstone dissolution therapy].
    Sugata F
    Nihon Rinsho; 1993 Jul; 51(7):1785-90. PubMed ID: 8366596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism.
    Adler RD; Bennion LJ; Duane WC; Grundy SM
    Gastroenterology; 1975 Feb; 68(2):326-34. PubMed ID: 1116678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid.
    Reuben A; Qureshi Y; Murphy GM; Dowling RH
    Eur J Clin Invest; 1986 Apr; 16(2):133-42. PubMed ID: 3089808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
    Maton PN; Murphy GM; Dowling RH
    Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
    Iser JH; Dowling H; Mok HY; Bell GD
    N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
    Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Br Med J; 1978 May; 1(6121):1171-3. PubMed ID: 638677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
    Iser JH; Murphy GM; Dowling RH
    Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile.
    Hirota I; Chijiiwa K; Noshiro H; Nakayama F
    Gastroenterology; 1992 May; 102(5):1668-74. PubMed ID: 1568577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incomplete dissolution of calculi. Calcification, cholecystectomy, after treatment of biliary lithiasis with chenodeoxycholic acid].
    Toulet J; Rousselet J; Viteau JM; Duchon Y; Pagniez R; Samain B; Vienne JL
    Gastroenterol Clin Biol; 1983 Dec; 7(12):969-74. PubMed ID: 6662332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Lancet; 1978 May; 1(8074):1111-4. PubMed ID: 77412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.